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Abstract
Background: The Migraine Disability Assessment (MIDAS) questionnaire is widely used to determine the degree of
migraine-related disability of subjects. So far, and to the best of our knowledge, no Spanish version of this tool has
been validated. The questionnaire comprises seven items, with the first five constituting the main scale while the
sixth and seventh items referring, respectively, to the frequency and intensity of headache. The present study aims
to analyze the clinimetric properties of the Spanish version of the MIDAS questionnaire in a population of university
students.
Methods: We performed a cross-sectional study of validation for this measuring instrument. A total of 153 subjects
participated in the study. We analyzed construct validity using factor analysis, test-retest reliability by the Intraclass
Correlation Coeficient (ICC), internal consistency, and concurrent validity with respect to the 12-Item Short Form
Health Survey (SF-12).
Results: Factor analysis revealed a two-factor structure. The questionnaire has good reliability for the MIDAS main-
scale score ([ICC = 0.81; 95% CI: 0.63–0.90]), excellent reliability for headache frequency (ICC = 0.90; 95%; CI: [0.79–
0.95]), and moderately good reliability for headache intensity (ICC = 0.63; 95% CI: [0.34–0.80]). The analysis also
yielded good internal consistency results (α Cronbach = 0.797) and a moderate correlation between MIDAS-main
scale and the physical component summary of SF-12 (Rho = − 0.326; p < 0.001).
Conclusions: The Spanish version of the MIDAS questionnaire is a valid and reliable tool to measure migraine-
related disability in university subjects. The two additional items provide information that could help clinicians in
making decisions.
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Background
Migraine is one of eight disorders that affect over 10% of
the world population [1]. It is one of the most common
chronic pain conditions among the young adult popula-
tion [2], with prevalence peaking between 20 and 30
years of age. Women [3] and students are some of the
populations most widely affected by migraine [4]. With a
large prevalence of around 37%, it involves a mean an-
nual cost per person of €1222, with Spain having the
highest total cost in Europe [3]. Since 1990 the number
of years lived with disability caused by migraine has in-
creased by 51.2% [5].
The Migraine Disability Assessment (MIDAS) ques-
tionnaire was developed as a tool to determine
headache-related disability [6]. It estimates productive
time lost to the disabling effects of headache over the
three preceding months.
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MIDAS has been transculturally adaptated to numer-
ous languages, and has been widely used for research
purposes and in clinical practice to develop treatment
strategies based on the patient’s level of disability [7]. To
the best of our knowledge, there is no validated Spanish
version of the MIDAS questionnaire, and its clinimetric
properties in that context remain unknown. However,
several studies have used the MIDAS questionnaire in
Spanish populations to determine both migraine-related
disability [8, 9] and the difficulty encountered by patients
when using the questionnaire [10].
Given the high prevalence and costs of migraine, par-
ticularly in Spain, and the lack of a reliable tool, written
in Spanish, to measure migraine-related disability, we
have analyzed the clinimetric properties of the Spanish
version of the MIDAS questionnaire in university stu-




This is an observational, cross-sectional study for the
validation of a measuring instrument, in which we have
analyzed the construct validity, internal consistency, and
concurrent validity of the MIDAS questionnaire. For
test-retest reliability, a subsample of 29 subjects was
evaluated twice with a time interval of 21 days.
Participants
The participants were young adult undergraduate and
graduate students over 18 years. In order to be included,
all participants were required to have been diagnosed
with migraine. They were then examined by a physician
(F.H.) to check if they fulfilled at that time the criteria
described in the third edition of The International Clas-
sification of Headache Disorders [11].
We followed recommendations to include at least 10
subjects per item and to have at least 100 subjects for
the purposes of the internal consistency and factor ana-
lysis [12]. A total of 230 subjects were contacted within
the University of Jaén (Spain), of which 202, aged be-
tween 18 and 33, participated in this study between the
months of March and June 2017. Finally, 153 partici-
pants met the inclusion criteria and completed all tasks.
The selection process is shown in Fig. 1.
The present study was approved by the Bioethics
Committee of the University of Jaén (Reference number
ABR 7/17) and was developed in accordance with the
Helsinki Declaration, good clinical practices, and all ap-
plicable laws and regulations. All participants provided
Fig. 1 Flow diagram of participants
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written informed consent prior to their inclusion in the
study.
Measurements
Prior to completing the questionnaires, the participants
reported their sociodemographic data including age,
gender, weight, height, smoking habit, and degree of
physical activity.
Two bilingual experts performed independent transla-
tions of the English version of the MIDAS questionnaire
[6] into Spanish, following the guidelines recommended
by the International Quality of Life Assessment project
for cross-cultural translation [13]. Secondly, a consensus
for a preliminary forward translation was reached be-
tween translators and researchers. Later, two bilingual
experts performed a backward translation of the agreed
Spanish version into English. The last English translation
was compared with the original version of the MIDAS
questionnaire in order to verify whether they had
achieved semantic, linguistic, conceptual, and technical
equivalence. Finally, 15 participants filled the Spanish
version of the questionnaire (Additional file 1) to verify
if the instructions, questions, and answering options
were understandable.
The MIDAS questionnaire measures the degree of
migraine-related disability experienced over the last 3
months. It comprises seven items, the first five of which
constitute the main scale and inquire about three dis-
tinct dimensions: workplace (two first items); domestic
tasks (third and fourth items); and attendance to social,
family, or leisure activities (fifth item). The sixth and
seventh items refer respectively to the frequency and in-
tensity of headaches over the last 3 months, and provide
relevant data for clinicians to make informed decisions.
The first six items must be answered with the number
of days that headache conditioned any of the activities
described in each question over the last 3 months. The
seventh item is a Numeric Pain Scale, in which zero in-
dicates absence of pain and ten indicates the maximum
pain subjects believe they can withstand. According to
the MIDAS-main scale score, which comprises the sum
of the answers to items 1 to 5, subjects could be classi-
fied in 5 disability grades: Grade I (score 0–5): no dis-
ability or low disability; Grade II (score 6–10): mild
disability; Grade III (score 10–20): moderate disability;
and Grade IV (score > 21): severe disability.
The 12-Item Short Form Health Survey (SF-12) was
used in the present study to measure quality of life [14].
This is a self-administered questionnaire extracted from
the SF-36 by means of multiple regression. The SF-12
consists of 12 items from which the physical and mental
component summaries (PCS-12 and MCS-12, respect-
ively) yield a single score each. These two summary
components showed high levels of internal consistency
(Cronbach’s alpha value of 0.85 for PCS-12 and 0.78 for
MCS-12) [14].
Statistical analysis
Data management and analysis were performed using
the IBM SPSS Statistics package, version 23.0 (SPSS Inc.,
Chicago, IL) and the MedCalc statistical software, ver-
sion 16.5.4 (MedCalc Software bv, Ostend, Belgium;
https://www.medcalc.org; 2019). Data were expressed as
means and standard deviations (SD) for continuous vari-
ables and as frequencies and percentages for categorical
variables. The Kolmogorov-Smirnov test was used to test
the normality of continuous variables. The level of statis-
tical significance was set at P < 0.05.
A Principal Component Analysis (PCA) with varimax
rotation was performed to measure the validity of the
MIDAS construct. To test the feasibility of the factorial
analysis we used Barlett’s sphericity test. The suitability
of the sample was analyzed using the Kaiser-Meyer-
Olkin (KMO) test.
Internal consistency of the instrument was assessed
through item analysis and the calculation of Cronbach’s
alpha. Values of Cronbach’s alpha below 0.70 were con-
sidered weak, between 0.70 and 0.90 were considered
good, and above 0.90 were interpreted as indicative of
item redundancy [15].
Test-retest reliability was analyzed using the Intraclass
Correlation Coeficient (ICC) as described by Shrout &
Fleiss. Reliability was considered low for ICC values
below 0.40, moderate for values between 0.40 and 0.75,
high for ICC values between 0.75 and 0.90, and excellent
for values higher than 0.90 [16].
Spearman’s correlation coefficient was used to analyze
the tool’s concurrent validity with the SF-12 question-
naire. A correlation coefficient greater than 0.5 indicated
a strong correlation, whereas values between 0.30 and
0.50 indicated a moderate correlation [17].
Results
Out of the 153 subjects who completed the study (aver-
age age = 21.76; SD = 3.65), 45 were men and 108 were
women. According to the disability level, 41.8% of par-
ticipants showed little to no disability, 32% showed mild
disability, 16.3% showed moderate disability, and 9.8%
showed severe disability (Table 1).
The PCA showed a structure composed of two factors.
The first factor included items 1, 3, and 5, which are
questions that imply refraining from engaging in activ-
ities, regardless of type, due to headache. The second
factor included items 2 and 4, which imply a decrease of
50% in the performance at work or at domestic tasks
(Table 2). The variance explained was 88.35%, Bartlett’s
sphericity test was statistically significant (X2 = 707.97;
p < 0.001), and the KMO index was 0.612, indicating
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that the sample used can be considered adequate for the
factor analysis.
Internal consistency analysis showed a Cronbach’s
alpha of 0.797 for the MIDAS-main scale score, which
may improve slightly if items 2 and 4 were eliminated
(Table 3). In addition, test-retest reliability was high for
the MIDAS-main scale score (ICC = 0.81 95% CI: 0.63–
0.90 p < 0.001), excellent for item 6 (headache fre-
quency; ICC = 0.90 95%; CI: 0.79–0.95; p < 0.001), and
moderate for item 7 (headache intensity; ICC = 0.63;
95% CI: 0.34–0.80; p < 0.001). The analysis showed a
strong correlation of the MIDAS-main scale score with
headache frequency, and a moderate correlation with
both headache intensity and PCS-12. Additionally, mod-
erate correlations were found between PCS-12 scores
and the frequency and intensity of headaches (Table 4).
Discussion
The MIDAS questionnaire has been used in Spanish
populations to assess migraine-related disability [8–10].
However, to the extent of our knowledge, there is no
validated Spanish version of the questionnaire, and this
is the first study to analyze the clinimetric properties of
the Spanish version of the MIDAS questionnaire. Our
results for a population of university students show a
factorial structure composed of two factors, good internal
consistency data, results ranging from good to excellent in
test-retest reliability, and a moderate correlation with
PCS-12 in the concurrent validity analysis of the question-
naire. Therefore, our results indicate that the Spanish ver-
sion of the MIDAS questionnaire is a valid and reliable
instrument to measure migraine-related disability.
However, our results showed a different factorial
structure to the one proposed by the original authors
[6]. Unlike the original structure, our PCA clearly identi-
fied two factors that explained nearly 90% of the vari-
ance. The first factor was composed of items that imply
refraining from certain activities, such as working, doing
house chores, or attending social events, due to migraine
(items 1, 3, and 5). The second factor was composed by
items that involve a 50% decrease in performance of
Table 1 Description of the participants
VARIABLES Migraineurs (n = 153)
CONTINUOUS Mean SD
Age 21.76 3.65
Height (cm) 168.18 7.95
Weight (kg) 64.93 11.95
BMI (kg/m2) 22.85 3.17
PCS-12 52.42 7.45
MCS-12 41.93 11.49
Frequency of headache (Item 6) 10.11 14.84
Pain intensity (Item 7) 5.48 2
CATEGORICAL F %
Gender Male 45 70.6
Female 108 29.4
Smoker Yes 21 13.7
No 132 86.3
Physical activity Yes 66 43.1
No 87 56.9
Kind of migraine Migraine 120 78.4
Chronic migraine 33 21.6
Attack duration 4 h 73 47.7
4-24 h 62 40.5
> 24 18 11.8
Photophobia Yes 84 54.9
No 69 45.1
Phonophobia Yes 104 68
No 49 32
Nausea or Vomiting Yes 90 58.8
No 63 41.2




BMI Body Mass Index, PCS-12 Physical Component Summary of the 12-Item
Short Form Health Survey (SF-12), MCS-12 Mental Component Summary of the
SF-12, MIDAS Migraine Disability Assessment
Table 2 Percentages of variance explained by the factor analysis performed using Principal Components Analysis
Component Initial eigenvalues Extraction sums of squared loadings Rotation sums of squared loadings
Total % of variancea Cumulative %b Total % of variancea Cumulative %b Total % of variancea Cumulative %b
1 2.846 56.922 56.922 2.846 56.922 56.922 2.823 56.460 56.460
2 1.571 31.428 88.350 1.571 31.428 88.350 1.595 31.890 88.350
3 0.429 8.585 96.935
4 0.113 2.254 99.188
5 0.041 0.812 100.000
aPercentage of variance that explains each factor of the questionnaire structure
bTotal percentage of variance explained jointly by the factors that compose the questionnaire structure
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both work-related and domestic tasks because of mi-
graine (items 2 and 4). This two-factor structure is indi-
cative of the variable influence that migraine has on
personal performance and, consequently, on disability.
In our population, nearly two thirds of migrainous
women and men presented some kind of disability, and
this was related to decreased physical quality of life.
These results are in agreement with previous studies [18,
19]. In addition to its physical effects, several cognitive
functions such as processing speed, attention, memory,
verbal skills, and executive function, which are all par-
ticularly important for the daily performance of our
population, are negatively affected by migraine [20] and
their debilitating consequences have a considerable im-
pact on daily-life activities [21]. In the present study, the
first factor of the factorial structure includes all items
that reflect total disability for the purposes of engaging
in any professional or social activity, while the second
factor reflects a partial disability level.
The reliability parameters of the Spanish version of
the MIDAS questionnaire were satisfactory as a whole.
We have obtained good internal consistency results,
comparable to those previous studies [18, 19, 22–24] in-
cluding the most recent ones [25, 26]. Results from the
test-retest reliability analysis ranged from good to excel-
lent. Our analysis also revealed that the two additional
items of the questionnaire are reliable and provide
relevant information that may be helpful for clinicians,
in agreement with statements made by the original au-
thors of the questionnaire [6]. The results obtained are
in accordance with the procedure for the measurement
of migraine-related disability proposed by the original
authors, although the factorial structure shown in the
present study was different. In fact, it suggests that
migraine-related disability may be assessed differently,
given the specific effects of migraine on cognitive func-
tions regardless of its severity, thereby generating differ-
ent disability levels that may lead from absenteeism to
presentism [4].
The results of the present study show good clinimetric
properties for the Spanish version of the MIDAS ques-
tionnaire, evidencing that this version is a consistent and
reliable measure tool.
This study has several limitations. Although the preva-
lence of migraine is high among student populations,
our results are only valid for the sample under analysis
and not be extrapolated to other populations. In
addition, our results may only be valid for a Spanish
population due to structural and organizational differ-
ences among the educational systems of different
countries.
Future studies should analyze the clinimetric proper-
ties of the MIDAS questionnaire for different popula-
tions and countries. It would be also advisable to
Table 3 Item reliability analysis
Average scale if the item is
deleted
Variance of scale if the item is
deleted
Corrected items - total
correlation




10.654 302.333 0.832 0.661
Item
2
8.765 538.878 0.134 0.851
Item
3
9.078 288.625 0.846 0.653
Item
4
9.137 523.040 0.203 0.842
Item
5
9.686 287.677 0.878 0.639
Item 1–5: questions in the MIDAS questionnaire
aCronbach’s alpha value if the item is deleted from the analysis
Table 4 Correlations among MIDAS-main scale score. Frequency and intensity of headache, and physical and mental components
summary of the SF-12 questionnaire
MIDAS-main scale score Headache frequency Headache intensity
Rho Spermann P Rho Spermann P Rho Spermann P
Headache frequency 0.529 < 0.001
Headache intensity 0.343 < 0.001 0.459 < 0.001
PCS-12 −0.326 < 0.001 −0.334 < 0.001 −0.268 < 0.001
MCS-12 −0.153 0.060 −0.029 0.721 −0.027 0.741
MIDAS Migraine Disability Assessment, PCS-12 Physical Component Summary of the 12-Item Short Form Health Survey (SF-12), MCS-12 Mental Component
Summary of the SF-12, MIDAS Migraine Disability Assessment
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examine the relation between headache and other con-
comitant disorders such as neck pain or dizziness, as
well as to analyze the factors related to the presence of
headache in university students and the impact that this
disorder may have on this population.
Conclusions
The Spanish version of the MIDAS questionnaire is a
valid and reliable tool for measuring migraine-related
disability in young university students. Moreover, the
two additional items of the questionnaire provide infor-
mation that can help clinicians discriminate between
subjects with and without headache, and enable a wider
application of this scale.
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